Skip to content

Ketamine: all studies

Page 171 of 449: studies 1,701 to 1,710 of 4,483, newest first. Back to the ketamine overview

Research

Esketamine ameliorates post-stroke anxiety by modulating microglial HDAC3/NF-κB/COX1 inflammatory signaling in ischemic cortex.

European Journal of Pharmacology March 28, 2023 Ailing Huang, Yang Chen, Shaoshuang Wang et al.

Post-stroke anxiety (PSA) is a kind of affective disorder occurring after a stroke, with anxiety as the primary clinical manifestation. PSA's mechanism is unclear, and there are few prevention and treatment measures. Our previous study found that HDAC3 could activate NF-κB signaling through mediated p65 deacetylation, which further influenced microglia activation. That implies HDAC3 may be the...

DOI: 10.1016/j.ejphar.2023.175667 (opens in new tab) Esketamine Microglia Animals Mice, inbred c57bl +6

Ketamine Evolving Clinical Roles and Potential Effects with Cognitive, Motor and Driving Ability

Neurology International March 28, 2023 Amber N. Edinoff, Saveen Sall, Colby B. Koontz et al. 5 citations

While driving under the influence of drugs, drivers are more likely to be involved in and cause more accidents than drivers who do not drive under the influence. Ketamine is derived from phencyclidine and acts as a noncompetitive antagonist and allosteric modulator of N-methyl-D-aspartate receptors. Ketamine has been used to treat a variety of psychiatric disorders, with the most notable being...

A Randomized, Double-Blind, Midazolam-Controlled Trial of Low-Dose Ketamine Infusion in Patients With Treatment-Resistant Depression and Prominent Suicidal Ideation

The International Journal of Neuropsychopharmacology March 26, 2023 T. Su, Cheng-Ta Li, Wei-Chen Lin et al. 48 citations

Abstract Background The benefits of low-dose ketamine for patients with treatment-resistant depression (TRD) and prominent suicidal ideation require further investigation. The effects of treatment refractoriness, the duration of the current depressive episode, and the number of prior antidepressant failures on ketamine efficacy also require clarification. Methods We recruited 84 outpatients...

Ketamine reduces the neural distinction between self- and other-produced affective touch - a double-blind placebo-controlled study

PsyArXiv March 23, 2023 preprint

A coherent sense of self is crucial for social functioning and mental health. The N-methyl-D-aspartate antagonist ketamine induces short-term dissociative experiences, modelling an altered state of self-perception. This randomized double-blind placebo-controlled within-subject study investigated the mechanisms for ketamine’s effects on the bodily sense of self. Participants received intravenous...

Acute Effects of Intravenous Sub-Anesthetic Doses of Ketamine and Intranasal Inhaled Esketamine on Suicidal Ideation: A Systematic Review and Meta-Analysis.

Neuropsychiatric Disease and Treatment March 14, 2023 Cheng-Chuan Chen, Na Zhou, Na Hu et al.

Purpose: Suicide is a major public health concern with currently no validated and efficacious treatments approved. Preliminary evidence suggests that intravenous ketamine has rapid and sustained antidepressant effects, making it a candidate with therapeutic potential for depressed patients at risk for suicide. We conducted a meta-analysis to evaluate the efficacy of ketamine and esketamine in...

Ketamine abuse Another side of the miracle drug

Journal of Clinical and Medical Images, Case Reports March 10, 2023 H Bouchra

Ketamine is a " dissociative anaesthetic " with fast analgesic and amnesic properties that has been used since more than 40 years. Today, ketamine abuse has become a public health concern. We report the case of a 23-year-old patient who came to the Casablanca Addictology Centre asking for help with ketamine abuse. At the interview the patient presented depressive symptoms and had already made 3...

Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.

Trends in Psychiatry and Psychotherapy March 7, 2023 Ana Teresa Caliman-Fontes, Gustavo C. Leal, Fernanda S. Correia-Melo et al.

Objectives: Evidence suggests that ketamine's influence on brain-derived neurotrophic factor (BDNF) might be involved in its mechanism of rapid antidepressant action. We aimed to evaluate the differential impact of ketamine and esketamine on serum BDNF levels and its association with response patterns in treatment-resistant depression (TRD). Methods: Participants (n = 53) are from a randomized,...

Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder.

Psychiatry Research March 5, 2023 Kevork Danayan, Noah Chisamore, Nelson B Rodrigues et al. 36 citations

Borderline personality disorder (BPD) has high rates of comorbidity with mood disorders, including treatment-resistant depression (TRD). Comorbidity of BPD with depression is associated with poorer response to antidepressants. Intravenous ketamine is a novel treatment for TRD that has not been specifically evaluated in patients with comorbid BPD. In this retrospective analysis of data collected...

Ketamine disrupts locomotion and electrolocation in a novel model of schizophrenia, Gnathonemus petersii fish

Journal of Neuroscience Research March 3, 2023 Veronika Langová, Petra Horká, Jan Hubený et al. 10 citations

The present study aimed to examine a weakly electric fish Gnathonemus petersii (G. petersii) as a candidate model organism of glutamatergic theory of schizophrenia. The idea of G. petersii elevating the modeling of schizophrenia symptoms is based on the fish's electrolocation and electrocommunication abilities. Fish were exposed to the NMDA antagonist ketamine in two distinct series differing...

DOI: 10.1002/jnr.25186 (opens in new tab) Ketamine Electroreception Schizophrenia object-oriented programming Fish <actinopterygii> +2

TOLERANCE AND ACCEPTABILITY OF INTRAVENOUS KETAMINE THERAPY FOR TREATMENT RESISTANT DEPRESSION: A MIXED METHODS ASSESSMENT

Journal of Pakistan Psychiatric Society March 3, 2023 Sawera Mansoor, Khalid Hayat Khan, Manzoor Ahmed Faridi 3 citations

Objectives: This study was conducted to evaluate the response of treatment resistant depression to IV ketamine therapy protocol and explore the perspectives of patients regarding the acceptability of this treatment modality. Study Design: Mixed methods assessment including Quasi experimental design and Qualitative interviews. Place and Duration of Study: The study was conducted at Department of...